Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomach Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Solid Tumor 1Prostatic Neoplasms 1Melanoma 1Carcinoma, Transitional Cell 1Advanced Solid Tumors 1Adenocarcinoma of the Stomach 1

Interventions

Gemcitabine 7Cystectomy 5Cisplatin 5durvalumab 4Neoadjuvant Therapy 4Mitomycin 4atezolizumab 3Transurethral Resection of Bladder 3Nivolumab 3Epirubicin 3Chemoradiotherapy 3BCG Vaccine 3Anesthesia, Spinal 3tislelizumab 2disitamab vedotin 2catumaxomab 2Vitamin E 2Urinary Diversion 2Sunitinib 2Selenium 2Robotic Surgical Procedures 2Multiparametric Magnetic Resonance Imaging 2Magnetic Resonance Imaging 2Immunohistochemistry 2Fentanyl 2Docetaxel 2Diathermy 2Cystoscopy 2Chemoprevention 2BCG Connaught 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Urinary Bladder Neoplasms × tesetaxel × Clear all
NCT01215877 2012-07-11

Tesetaxel for Previously Treated Patients With Bladder Cancer

Genta Incorporated

Phase 2 Unknown
33 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡